The vaccine is intended for use in horses for which a risk of Streptococcus equi infection has been clearly identified, due to contact with horses from areas where this pathogen is known to be present, e. g. stables with horses that travel to shows and/ or competitions in such areas, or stables that obtain or have livery horses from such areas.